Pharmaceutical Drug Delivery Market Worth $2,206.5 Billion by 2026 - Exclusive Report by MarketsandMarkets™
In July 2021, Johnson & Johnson received FDA approval for DARZALEX (daratumumab), a subcutaneous formulation that reduces the treatment time for multiple myeloma indications.
View full press release